Zostań subskrybentem
Newsroom
Arjo India celebrates 25 years of serving customers
This month Arjo is celebrating the 25th anniversary of introducing Arjo's products to the Indian market, coming at a time when providing solutions for various conditions arising out of immobility is more important than ever.
Arjo Australia wins excellence in sustainability award for revolutionary healthcare initiative
Arjo Australia has been awarded the Excellence in Sustainability Award for its ground-breaking Arjo ReNu reprocessing solution, which transforms healthcare sustainability through innovative medical device reprocessing.The award recognises organisations demonstrating exceptional leadership in sustainable business practices and alignment with the...
Arjo receives the Allbright Prize 2024
The medical technology company Arjo has been awarded the 2024 Allbright Prize for purposeful and long-term work with equality, diversity and inclusion. The prize was awarded at a ceremony in Stockholm today.
Arjo and Bruin Biometrics conclude distribution agreement, Bruin Biometrics resumes direct sales and marketing of Provizio[®] SEM Scanner
Today Arjo and Bruin Biometrics announce the immediate transition of direct sales and marketing of the Provizio[®] SEM Scanner to Bruin Biometrics, following four years of cooperation between the companies.
Flowtron ACS900 improvement reduces costs and emissions
As part of the recent upgrade of the Flowtron ACS900 pump, a redesign of the circuit board helps users of Arjo’s active compression system to reduce energy costs and emissions. The new version has about 14% lower energy consumption than its predecessor.
Arjo’s interim report January-September 2024
”Growth continued in the quarter with a strengthened order book and improved gross margin. Our performance was, however, held back by weaker demand in Europe. We are now accelerating initiatives to improve both short- and long-term profitability. We enter the final quarter of the year with high activity level and expect to reach our ambition of 3-5...
Arjo announces date for 2024 Q3 report and conference call
Arjo will issue its interim report for Q3 on Thursday October 17 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO, and Niclas Sjöswärd, CFO.
Arjo strengthens its positions in diagnostics and rentals through two European acquisitions
The medical technology company Arjo has signed agreements to acquire the French company Tech Med, one of the Group's existing distributors within diagnostics, and the German company GerroMed, provider of rental solutions focused on pressure injury prevention.
Optimizing customer value with Arjo’s Guide for Architects and Planners
The Queen Elizabeth Hospital Redevelopment outside Adelaide in Australia is an example of how Arjo works closely with builders and architects to help create an efficient care facility with space for the company’s solutions to deliver optimal value. The project also includes Arjo’s largest installations of ceiling hoists in South Australia.
Arjo announces opening of new reprocessing facility to enhance production capacity and customer service
Arjo, a global healthcare leader committed to driving healthier outcomes for people facing mobility challenges, is excited to announce the opening of its new state-of-the-art facility for reprocessing medical devices. The new space, 50% larger than the previous location, is designed to increase the production output and significantly improve...
Solar energy covers almost 50% of the energy consumption in Arjo factory
Arjo’s first large-scale solar energy installation is now up and running on the rooftops of the company’s Suzhou factory in eastern China. Generating up to 600 MWh of electricity yearly, the installation is expected to cover almost 50 percent of the factory’s total energy consumption.
Arjo’s interim report January-June 2024
”Our journey towards long-term profitability improvement continues and we deliver yet another quarter of growth and increased profitability. The positive development in rental and service continued globally and we navigate the market in a good way, despite short-term challenges. There is a major need for investments in healthcare and overall we see...
Arjo announces date for 2024 Q2 report and conference call
Arjo will issue its interim report for Q2 on Friday July 12 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO, and Niclas Sjöswärd, CFO.
Arjo in a leading position on dementia certified products
With more products certified specifically to meet the unique demands of dementia care than any other manufacturer[1], Arjo is in a leading position to help care providers address the challenges. A position made even stronger thanks to two new additions to the lineup.
Arjo presenting at leading conference on sustainability in healthcare
Arjo is presenting at CleanMed 2024, the leading conference dedicated to sustainability in healthcare. The event will take place in Salt Lake City from May 21 to 23. Arjo will highlight innovations to enhance the sustainability performance of medical devices and methods for reprocessing.
Arjo not extending distribution agreement for Provizio® SEM scanner – no impact to the Group’s 2024 outlook
Arjo has decided not to extend the distribution agreement for Bruin Biometrics’ Provizio SEM scanner. The reason is that the parties are too far apart in terms of expected commercial development. Arjo’s outlook of 3-5% organic net sales growth for 2024 stands firm.
Resolutions at Arjo’s Annual General Meeting 2024
Arjo AB (publ) held the Annual General Meeting on Thursday 18 April 2024 in Malmö. At the Annual General Meeting the following was resolved:
Arjo’s interim report January-March 2024
”We start the year with growth and improved profitability. Rental and service develop well globally and the positive trend in the US continues, with a gradual improvement of the market situation. Overall, a solid start to the year and I look forward to continue the work together with the team to strengthen Arjo’s positions in 2024,” says Joacim...
Arjo announces date for 2024 Q1 report and conference call
Arjo will issue its interim report for Q1 on Thursday April 18 at 14:00 CEST, followed by a conference call at 15:00 CEST, hosted by Joacim Lindoff, President & CEO, and Niclas Sjöswärd, CFO.
Arjo publishes its Annual and Sustainability Report for 2023
Arjo’s Annual and Sustainability Report for 2023 is now available on the Group’s website.
NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB (PUBL)
The shareholders of Arjo AB (publ), Corporate ID No. 559092-8064, are hereby invited to attend the Annual General Meeting (the “AGM”) on Thursday, 18 April 2024 at 5.00 p.m. CEST, at Glasklart, Dockplatsen 1, Malmö, Sweden.
Arjo’s climate targets approved by Science Based Targets initiative
Arjo’s climate targets are in line with the latest climate science and the Paris Agreement. This was confirmed by the Science Based Targets initiative (SBTi), which has now validated the company’s climate targets.
Arjo’s year-end report January-December 2023
”We are ending 2023 with healthy growth, significantly improved earnings and strong operating cash flow. During the year considerable focus was put on profitable growth in a market characterized by stabilization and recovery. We are now continuing our efforts to further strengthen our positions during 2024 and beyond,” says Joacim Lindoff,...
Arjo announces date for 2023 year-end report and conference call
Arjo will issue its year-end report for 2023 on Tuesday January 30 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Niclas Sjöswärd, CFO.
Zero pressure injuries in successful Provizio SEM Scanner project
Arjo has partnered with the UK care company Highland Home Carers (HHC) in an award-winning pressure injury prevention pilot using the Provizio[®] SEM Scanner – with zero pressure ulcers developing throughout the project.
